{"id":"https://openalex.org/W2775554376","doi":"https://doi.org/10.1080/13543776.2018.1414183","title":"FAK inhibitors in Cancer, a patent review","display_name":"FAK inhibitors in Cancer, a patent review","publication_year":2017,"publication_date":"2017-12-06","ids":{"openalex":"https://openalex.org/W2775554376","doi":"https://doi.org/10.1080/13543776.2018.1414183","mag":"2775554376","pmid":"https://pubmed.ncbi.nlm.nih.gov/29210300"},"language":"en","primary_location":{"id":"doi:10.1080/13543776.2018.1414183","doi":"https://doi.org/10.1080/13543776.2018.1414183","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543776.2018.1414183","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061890892","display_name":"Peng\u2010Cheng Lv","orcid":"https://orcid.org/0000-0001-5552-9364","observed_orcids":["https://orcid.org/0000-0001-5552-9364"]},"institutions":[{"id":"https://openalex.org/I4391768045","display_name":"State Key Laboratory of Pharmaceutical Biotechnology","ror":"https://ror.org/043ea4m21","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng-Cheng Lv","raw_affiliation_strings":["Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","institution_ids":[]},{"raw_affiliation_string":"State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China","institution_ids":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ai-Qin Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391768045","display_name":"State Key Laboratory of Pharmaceutical Biotechnology","ror":"https://ror.org/043ea4m21","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ai-Qin Jiang","raw_affiliation_strings":["Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","institution_ids":[]},{"raw_affiliation_string":"State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China","institution_ids":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001057120","display_name":"Weiming Zhang","orcid":"https://orcid.org/0000-0001-5263-0512","observed_orcids":["https://orcid.org/0000-0001-5263-0512","https://orcid.org/0000-0001-5576-6108","https://orcid.org/0009-0005-0035-0670"]},"institutions":[{"id":"https://openalex.org/I4391768045","display_name":"State Key Laboratory of Pharmaceutical Biotechnology","ror":"https://ror.org/043ea4m21","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Wei-Ming Zhang","raw_affiliation_strings":["Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","institution_ids":[]},{"raw_affiliation_string":"State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China","institution_ids":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100376356","display_name":"Hai\u2010Liang Zhu","orcid":"https://orcid.org/0000-0003-4738-7655","observed_orcids":["https://orcid.org/0000-0003-4738-7655"]},"institutions":[{"id":"https://openalex.org/I4391768045","display_name":"State Key Laboratory of Pharmaceutical Biotechnology","ror":"https://ror.org/043ea4m21","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Hai-Liang Zhu","raw_affiliation_strings":["Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing, P. R. China","institution_ids":[]},{"raw_affiliation_string":"State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing P. R. China","institution_ids":["https://openalex.org/I4391768045","https://openalex.org/I881766915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001057120","https://openalex.org/A5100376356"],"corresponding_institution_ids":["https://openalex.org/I4391768045","https://openalex.org/I881766915"],"apc_list":null,"apc_paid":null,"fwci":1.3517,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.79240506,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"28","issue":"2","first_page":"139","last_page":"145"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/focal-adhesion-kinase","display_name":"focal adhesion kinase","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fak-inhibitors","display_name":"FAK inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/non-receptor-tyrosine-kinase","display_name":"non-receptor tyrosine kinase","score":0.9129999876022339},{"id":"https://openalex.org/keywords/integrin-signaling","display_name":"integrin signaling","score":0.8259999752044678},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.8980000019073486},{"id":"https://openalex.org/keywords/anticancer-drug-design","display_name":"anticancer drug design","score":0.6669999957084656},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9629999995231628},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.527999997138977},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.9330000281333923},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C151166631","wikidata":"https://www.wikidata.org/wiki/Q904514","display_name":"Focal adhesion","level":3,"score":0.8318253755569458},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.6957261562347412},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6042853593826294},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5763950347900391},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5523678064346313},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.5518638491630554},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.49440503120422363},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.49166303873062134},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.44028523564338684},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.43293508887290955},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41858041286468506},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3810245394706726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3396924138069153},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2814258635044098},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1323426365852356},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051416","descriptor_name":"Focal Adhesion Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051416","descriptor_name":"Focal Adhesion Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13543776.2018.1414183","doi":"https://doi.org/10.1080/13543776.2018.1414183","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543776.2018.1414183","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},{"id":"pmid:29210300","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29210300","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic patents","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1966296292","https://openalex.org/W1971538947","https://openalex.org/W1974625510","https://openalex.org/W1985961293","https://openalex.org/W1986830863","https://openalex.org/W1987228194","https://openalex.org/W1998819602","https://openalex.org/W2002547287","https://openalex.org/W2006145157","https://openalex.org/W2010040669","https://openalex.org/W2014280822","https://openalex.org/W2016656045","https://openalex.org/W2021705436","https://openalex.org/W2035922600","https://openalex.org/W2036446081","https://openalex.org/W2037589400","https://openalex.org/W2044895919","https://openalex.org/W2051209895","https://openalex.org/W2052647859","https://openalex.org/W2065088072","https://openalex.org/W2068652698","https://openalex.org/W2074070818","https://openalex.org/W2091506455","https://openalex.org/W2092455965","https://openalex.org/W2096960044","https://openalex.org/W2102498455","https://openalex.org/W2107200488","https://openalex.org/W2131827371","https://openalex.org/W2147310459","https://openalex.org/W2155207597","https://openalex.org/W2163802608","https://openalex.org/W2171179595","https://openalex.org/W2324366448","https://openalex.org/W2330212966","https://openalex.org/W2332843085","https://openalex.org/W2469223980","https://openalex.org/W2515900569","https://openalex.org/W2548401715","https://openalex.org/W2592858806","https://openalex.org/W2603962019","https://openalex.org/W2614486214","https://openalex.org/W2750210658"],"related_works":["https://openalex.org/W3105055377","https://openalex.org/W3147995405","https://openalex.org/W1970304603","https://openalex.org/W4400212660","https://openalex.org/W2123956915","https://openalex.org/W3092697214","https://openalex.org/W3179724822","https://openalex.org/W1998819602","https://openalex.org/W4210346397","https://openalex.org/W4391751791"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Focal":[1],"adhesion":[2,16],"kinase":[3,9],"(FAK)":[4],"is":[5,34,79],"a":[6,80],"non-receptor":[7],"tyrosine":[8],"that":[10,62,77,152],"localizes":[11],"at":[12],"sites":[13],"of":[14,27,30,73,136],"cell":[15,38,113],"to":[17,36,51,107,117],"the":[18,31,71,129,149,159],"extracellular":[19],"matrix":[20],"(ECM)":[21],"and":[22,41,65,93,120,132,157],"mediates":[23],"signalling":[24],"events":[25],"downstream":[26],"integrin":[28],"engagement":[29],"ECM.":[32],"FAK":[33,45,78,88,139,150],"known":[35],"regulate":[37],"survival,":[39],"proliferation":[40],"migration.":[42],"AREAS":[43],"COVERED:":[44],"expression":[46],"has":[47],"also":[48,60,147],"been":[49,91],"shown":[50],"be":[52,108],"up-regulated":[53],"in":[54,70,97,115,154],"many":[55],"cancer":[56],"types.":[57],"Previous":[58],"study":[59],"indicates":[61],"FAK-mediated":[63],"signaling":[64],"functions":[66],"are":[67,94,153],"intrinsically":[68],"involved":[69],"progression":[72],"tumor":[74,112],"aggressiveness,":[75],"suggesting":[76],"promising":[81],"target":[82],"for":[83],"anticancer":[84],"therapies.":[85],"Small":[86],"molecule":[87,138],"inhibitors":[89,104,140,151],"have":[90,105],"developed":[92],"being":[95],"tested":[96],"clinical":[98,155],"phase":[99],"trials.":[100],"EXPERT":[101],"OPINION:":[102],"These":[103],"demonstrated":[106],"effective":[109],"by":[110],"inducing":[111],"apoptosis":[114],"addition":[116],"reducing":[118],"metastasis":[119],"angiogenesis.":[121],"In":[122],"this":[123],"review,":[124],"we":[125],"give":[126],"updates":[127],"on":[128],"design,":[130],"synthesis":[131],"structure-activity":[133],"relationship":[134],"analysis":[135],"small":[137],"discovered":[141],"from":[142],"2015":[143],"until":[144],"now.":[145],"We":[146],"review":[148],"development":[156],"highlight":[158],"future":[160],"prospects.":[161]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-12-22T00:00:00"}